SMITH SANDFORD D
SEC CIK 1243004 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | Dir | 18.8K | — | $3.45M | 22 | 2021-07-01 | 2024-01-02 |
Most active insiders at CYTK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| 2 | Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| 3 | Lee Sung | EVP, CFO | — | $5.70M |
| 4 | Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| 5 | Kaye Edward M. MD | Dir | — | $3.21M |
| 6 | HENDERSON JOHN T | Dir | — | $2.08M |
| 7 | WIERENGA WENDELL | Dir | — | $1.88M |
| 8 | PARSHALL B LYNNE | Dir | — | $1.36M |
| 9 | Landry Robert E | Dir | — | $146.8K |
| 10 | Harrington Robert Arthur | Dir | — | $143.6K |
SMITH SANDFORD D made no open-market trades at CYTK in the last 12 months.
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-03 | 2024-01-02 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $84.12 | +148 | 18.8K | +0.8% | +$12.4K | |
| 2023-10-03 | 2023-10-02 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $27.88 | +448 | 18.7K | +2% | +$12.5K | |
| 2023-07-05 | 2023-07-03 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $33.36 | +374 | 18.2K | +2% | +$12.5K | |
| D | 2023-05-18 | 2023-05-10 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $0.00 | +5,000 | 17.8K | +39% | $0 |
| 2023-04-05 | 2023-04-03 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $37.71 | +298 | 12.8K | +2% | +$11.2K | |
| 2023-01-04 | 2023-01-03 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $44.35 | +253 | 12.5K | +2% | +$11.2K | |
| 2022-10-05 | 2022-10-03 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $51.11 | +110 | 12.3K | +0.9% | +$5,622 | |
| D | 2022-09-02 | 2022-09-02 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | S - Sale+OE | $53.97 | -11.4K | 12.2K | -48% | -$613.6K |
| DM | 2022-09-02 | 2022-09-02 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | M - OptEx | $23.66 | +11.4K | 15.2K | +296% | +$269.0K |
| 2022-07-12 | 2022-07-01 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $41.00 | +137 | 12.2K | +1% | +$5,617 | |
| D | 2022-05-11 | 2022-05-10 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $0.00 | +5,000 | 12.0K | +71% | $0 |
| 2022-04-01 | 2022-04-01 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $38.38 | +146 | 7,033 | +2% | +$5,603 | |
| 2022-01-04 | 2022-01-03 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $46.00 | +122 | 6,887 | +2% | +$5,612 | |
| DM | 2021-12-28 | 2021-12-27 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | M - OptEx | $21.11 | +28.3K | 10.9K | New | +$597.2K |
| DM | 2021-12-28 | 2021-12-27 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | S - Sale+OE | $45.79 | -28.3K | 6,765 | -81% | -$1.30M |
| DM | 2021-11-19 | 2021-11-19 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | S - Sale+OE | $41.21 | -29.0K | 6,765 | -81% | -$1.20M |
| DM | 2021-11-19 | 2021-11-19 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | M - OptEx | $13.17 | +29.0K | 26.8K | New | +$382.2K |
| 2021-10-04 | 2021-10-01 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $36.74 | +306 | 6,765 | +5% | +$11.2K | |
| DM | 2021-07-21 | 2021-07-19 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | S - Sale+OE | $28.87 | -12.0K | 6,459 | -65% | -$345.5K |
| DM | 2021-07-21 | 2021-07-19 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | M - OptEx | $10.68 | +12.0K | 8,424 | New | +$127.8K |
| 2021-07-08 | 2021-07-07 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $19.77 | +63 | 6,459 | +1.0% | +$1,246 | |
| 2021-07-02 | 2021-07-01 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Dir | A - Grant | $20.98 | +476 | 6,396 | +8% | +$9,986 |
Purchase Sale Sale after option exercise All abbreviations